Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06205810 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06205810 · ClinicalTrials.gov record · last posted 2026-01-20

The COMPLETE Study

Study acronym: COMPLETE
StatusRecruiting
PhaseNot specified
Started2023-10-24
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The COMPLETE study is a single-centre, investigator-initiated study of patients with an indication for invasive coronary angiography with CCTA performed during the diagnostic evaluation. After identifying the presence of a coronary stenosis, defined as an epicardial lesion \>50% stenosis on CCTA, patients eligible for the study will be invited to participate. The main aim of this trial is to assess the accuracy of coronary CT angiography to quantify total atheroma volume with intravascular ultrasound as reference. Patients will be divided into 2 sub-groups: Cohort 1: Patients with stable coronary artery disease or stabilized acute coronary syndromes with a clinical indication for invasive coronary angiography. Cohort 2: Patients previously revascularized with a metallic stent with a clinical indication for invasive coronary angiography. In both cohorts, patients should have undergone coronary CT angiography as part of the standard of care. Patients included in the study will be managed according to the standard of care for the assessment of coronary artery disease. Clinical follow-up will be collected until 3 years follow-up.

Amendment record 2 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 2 times since 2024-01-03; most recent amendment 2026-01-16. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

Trial Details
NCT Number NCT06205810
Lead Sponsor CoreAalst BV
Collaborators: HeartFlow, Inc.
Conditions Coronary Artery Disease
Enrollment 250 participants
Start Date 2023-10-24
Primary Completion 2030-10-15 (estimated)
Study Completion 2031-10-15 (estimated)
Updated on ClinicalTrials.gov 2026-01-20